Artificial Intelligence | Machine Learning Xilis | Precision Oncology & Drug Development


Enterprise, Biotechnology, Health Care, Life Science, Oncology, Precision Medicine Durham, North Carolina, United States

Xilis

Artificial Intelligence | Machine Learning


Xilis | Precision Oncology & Drug Development

Xilis

Biotechnology, Health Care, Life Science, Oncology, Precision Medicine


Durham, North Carolina, United States

Developing next-generation technologies for precision medicine and drug discovery. Developed by world-class scientists from the U.S. and Europe, Xilis’ MicroOrganoSphereTM (MOS) technology and Precision Oncology Platform are transforming treatment choices in the clinic and bringing novel therapeutics to patients.

Xilis is developing next-generation technologies to guide precision therapy for cancer patients and accelerate drug discovery and development. MOS are microscale tumors that retain structure, genetic alterations, gene expression, immune microenvironment, and histopathology from individual patients. Our MOS platform enables rapid diagnostics for personalized therapy prioritization by predicting patient response, and scalable patient-derived models for high-throughput and immuno-oncology drug discovery.

Xilis’ Precision Oncology Platform enables clinicians to make timely treatment decisions by predicting patient treatment response and guiding optimal therapeutic options. The Xilis Precision Oncology Platform and Xilis Response Score™ can guide prioritized treatment decisions for oncologists and ensure patients get the right drug at the right time.

The MOS technology is transforming cancer drug development by providing an end-to-end patient-centric solution. Our breakthrough platform provides cost-effective, high-throughput drug candidate screening, pre-clinical assessment of immuno-oncology drugs, personalized assays to determine patient eligibility for clinical trials, and companion diagnostics to guide patients to newly developed treatments.

 

B2B

1 to 25

Series A

$92M

Scaling Up

2019

 
 

Pharmaceuticals
Healthcare
Biotechnology

Prioritized Treatment Decisions
Predicting Patient Treatment Response

Increase Productivity
Increase Efficiency

 
 

Service

Yes

Active

 
 

   Machine Learning


Precision Health Platform

Precision Health Platform


Image

Image

Text

Text

Structured

Structured

 

   Software


Kubernetes

Kubernetes

Docker

Docker

Python

Python

Linux Shell

Linux Shell

Postgres

Postgres

AWS

AWS

C/C++

C/C++


Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

View All

View All AI/ML Jobs

Staff Data Scientist

Remote, Remote

Data Engineer

Remote, Remote

Research Associate (R&D)

Durham, North Carolina

Senior Scientist (Diagnostics)

Durham, North Carolina

Head OF Microfluidics

Durham, North Carolina

 

AI/ML Professionals

Want to work at Xilis?

We can introduce you to the right person at Xilis

Talk to our Talent Team

 

13

2

$44.5M

Company was founded 2019 and it took almost 2 years (Jul 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

07/13/2022

Series A

$19M

FPV Ventures, Alexandria Venture Investments, EQT, Mubadala Capital Ventures, Pear VC, GV, Duke Angel Network, Catalio Capital Management, Two Sigma Ventures, Felicis Ventures

Date : 07/13/2022

Round: Series A

$ Raised: $19M

Investors: FPV Ventures, Alexandria Venture Investments, EQT, Mubadala Capital Ventures, Pear VC, GV, Duke Angel Network, Catalio Capital Management, Two Sigma Ventures, Felicis Ventures

07/08/2021

Series A

$70M

Two Sigma Ventures, Pear VC, Mubadala Capital Ventures, LSP BioVentures, KdT Ventures, GV, Felicis Ventures, Catalio Capital Management, Alix Ventures

Date : 07/08/2021

Round: Series A

$ Raised: $70M

Investors: Two Sigma Ventures, Pear VC, Mubadala Capital Ventures, LSP BioVentures, KdT Ventures, GV, Felicis Ventures, Catalio Capital Management, Alix Ventures

 

Investors

Interested in researching Xilis?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Xilis

Request a Demo - Deal Souring Platform

 
Daniel Delubac


Daniel Delubac
VP Platform and Chief Operating Officer

Xiling Shen

Xiling Shen
CEO

Gary Yeung

Gary Yeung
CFO and President

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Xilis